LFCR

Lifecore Biomedical, Inc.

$6.37

0.00%
SectorHealthcareIndustryDrug Manufacturers - Specialty & GenericCountryUnited States

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications.

Source: Yahoo Finance
AI summary

Price & performance

1M-1.8%
3M+44.1%
YTD-17.3%
1Y-5.5%
52-week range—
Beta1.32
Full chart and returns against a benchmark

Q-Score

41/ 100

Quality against peers; 50 is the peer median.

Growth43
Risk55
Performance50
Valuation28
Profitability45
Leverage46
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$128.9M+0.5%
Net income-$38.7M-422.3%
Net margin-30.0%-39.4 pts
Historical fundamentals

Red flags in filings

2active red flags
Material weakness in controlsMar 16, 2026
Auditor changeAug 18, 2025
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer44%
Regions, segments, customers and suppliers

Valuation

LFCRIndustryP/E—35.25P/S1.872.74EV/EBITDA—16.35P/B180.732.46PEG—0.87
Dividend yield0.00%
Every valuation metric

Earnings

Nov 3next report
EPS estimate—
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate